Kian Sadeghi
@KianSadeghi5 • 13,043 subscribers
Founder, CEO @NucleusGenomics | IVF built for genetic optimization | @zfellows @thielfellowship
Videos
Longevity is now for embryos. Nucleus Embryo is the first-ever genetic optimization software that helps parents give their children the best possible start in life — long before they’re even born. Longevity was never just about health. It’s about thriving. That’s why this announcement also marks the first time in human history a company has openly partnered with a couple to help them optimize their embryos based on intelligence.
Kian Sadeghi886,810 görüntüleme • 1 yıl önce
After four and a half years of building, I’m beyond excited to announce today family planning via genetic matching on Nucleus Genomics. Imagine knowing nearly every possible genetic outcome for you and your partner’s future children, starting with your future children’s risk of inheriting over 900 diseases. In the future, all couples everywhere will check their genetic compatibility before having children. In doing so, couples can choose not to pass down hereditary disease to their kids. This is what modern genomic science is about — building tools that lets anyone, anywhere be healthy and have healthy children. What better way to announce genetic matching than syncing with Molly O’Shea? Watch to find out if we’re compatible😉
Kian Sadeghi682,943 görüntüleme • 1 yıl önce
AI can now predict your future — before you’re born. Nucleus Genomics just launched Origin, disease models trained on 1.5M genomes combining 7M genetic markers. Origin predicts human longevity from embryo DNA more accurately than any model ever built. And it’s open-weighted.
Kian Sadeghi154,159 görüntüleme • 7 ay önce
Thousands of future parents reached out when we launched Nucleus Embryo. But we quickly realized that just creating genetic optimization wasn’t enough. That’s why we’re launching Nucleus IVF+ — a new IVF option for parents who want to give their child the best possible start in life. Longevity begins before birth. That vision is bigger than just genetics.
Kian Sadeghi97,340 görüntüleme • 9 ay önce
$14M in fresh funding will help us scale, but most importantly, it fuels what’s coming next: AI-powered insights, deeper integrations, and a complete rethinking of family planning and genetic health. We’re just getting started. Watch the video for what’s next:
Kian Sadeghi22,467 görüntüleme • 1 yıl önce
I'm excited to announce we have reimagined the Nucleus Genomics homepage. It is now easier than ever to view, sort, and organize your genetic analysis results. I want to thank our customers for their extensive feedback and notes, enabling us to create something to better serve you. This new platform prepares us for our largest update ever — adding in 600+ analyses.
Kian Sadeghi16,682 görüntüleme • 1 yıl önce
I sat down with Dr. Veera Rajagopal (Veera Rajagopal ) - physician-scientist at Regeneron and one of the best communicators in genetics - to talk about how genetics is transforming drug discovery and healthcare. We get into how human genetics is used to find new drug targets, why 23andMe’s model failed, the real impact of AI on genetic research, and why whole genome sequencing is the future. 0:00:00 – Dr. Rajagopal’s path from medicine to genetics 0:07:48 – Moving to industry, & the shift from academia 0:13:57 – Scaling science vs. pure research 0:18:18 – Why 23andMe’s Model Didn’t Work & the future is whole genome 0:28:53 – How AI is (and isn’t) changing genomics 0:43:12 – What people misunderstand about genetic drug discovery 0:51:22 – The future of genomics and the mission of Nucleus
Kian Sadeghi11,253 görüntüleme • 1 yıl önce
Daha fazla içerik yok.